Case?control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients-Reference-Cited by-同舟云学术

Case?control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients

Published:2007-01 Issue:1 Volume:136 Page:87-95
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Malagola Michele,Damiani Daniela,Martinelli Giovanni,Michelutti Angela,Cesana Bruno,Vivo Antonio De,Piccaluga Pier Paolo,Ottaviani Emanuela,Candoni Anna,Geromin Antonella,Tiribelli Mario,Fanin Renato,Testoni Nicoletta,Lauria Francesco,Bocchia Monica,Gobbi Marco,Pierri Ivana,Zaccaria Alfonso,Zuffa Eliana,Mazza Patrizio,Priccolo Giancarla,Gugliotta Luigi,Bonini Alessandro,Visani Giuseppe,Skert Cristina,Bergonzi Cesare,Roccaro Aldo Maria,Filí Carla,Baccarani Michele,Russo Domenico

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06390.x/fullpdf

Reference40 articles.

1. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

2. Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

3. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

4. Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flai (fludarabine, cytarabine, idarubicin) plus low-dose Gemtuzumab Ozogamicin as induction therapy in CD33-positive AML: Final results and long term outcome of a phase II multicenter clinical trial;American Journal of Hematology;2018-03-02

2. Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia;Annals of Hematology;2016-08-19

3. Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia;Blood Reviews;2016-01

4. Do ABC proteins still have a role to play in acute myeloid leukemia?;Hématologie;2014-09

5. Targeting MDR1-P-glycoprotein (MDR1-Pgp) in immunochemotherapy of acute myeloid leukemia (AML);ANN I SUPER SANITA;2013